1. Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling
   Catríona Dowling et al, 2015, Cancers CrossRef
2. Down-regulation of protein kinase Cη potentiates the cytotoxic effects of exogenous tumor necrosis factor–related apoptosis-inducing ligand in PC-3 prostate cancer cells
   Jürgen Sonnemann et al, 2004, Molecular Cancer Therapeutics CrossRef
3. The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C α/c-Src/IκB Kinase α/β–Dependent Prostate Tumor Progression and Angiogenesis
   Shalini Jain et al, 2006, Cancer Research CrossRef
4. Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis
   Jeewon Kim et al, 2008, Cancer Research CrossRef
5. Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer
   Michael A. Carducci et al, 2006, Journal of Clinical Oncology CrossRef
6. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
   Takahito Kawano et al, 2022, Cancers CrossRef
7. Targeting Protein Kinase C for Cancer Therapy
   Sijia He et al, 2022, Cancers CrossRef
8. Enzastaurin, a Protein Kinase Cβ–Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer
   Roy S. Herbst et al, 2007, Clinical Cancer Research CrossRef
9. GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer
   Shintaro Narita et al, 2008, Clinical Cancer Research CrossRef
10. Synthesis and Anticancer Evaluation of Novel Derivatives of Isoxazolo[4,5-e][1,2,4]triazepine Derivatives and Potential Inhibitors of Protein Kinase C
    Edwin Wagner et al, 2021, ACS Omega CrossRef